Cargando…

Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma

BACKGROUND: Cancer stem cells (CSC) may respond to chemotherapy differently from other tumor cells. METHODS: This study examined the expression of the putative cancer stem cell markers ALDH1, CD44, and CD133; the angiogenesis marker CD31; and the macrophage marker CD68 in soft tissue sarcomas (STS)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skubitz, Keith M., Wilson, Jon D., Cheng, Edward Y., Lindgren, Bruce R., Boylan, Kristin L. M., Skubitz, Amy P. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471853/ https://www.ncbi.nlm.nih.gov/pubmed/30999901 http://dx.doi.org/10.1186/s12967-019-1883-6

Ejemplares similares

Prospective Trial of Monocyte Count as a Biomarker of Hand-Foot Syndrome Among Patients With Soft Tissue Sarcomas Treated With Pegylated Liposomal Doxorubicin and Ifosfamide
por: Skubitz, Keith M, et al.
Publicado: (2022)

Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors
por: Skubitz, Keith M, et al.
Publicado: (2008)

Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide
por: Skubitz, Keith M., et al.
Publicado: (2022)

Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas
por: Skubitz, Keith M, et al.
Publicado: (2014)

Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
por: Savani, Malvi, et al.
Publicado: (2019)

Giant cell tumor of the uterus: case report and response to chemotherapy
por: Skubitz, Keith M, et al.
Publicado: (2007)

Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4
por: Boylan, Kristin L.M., et al.
Publicado: (2020)

Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells
por: Skubitz, Keith M, et al.
Publicado: (2008)

Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma
por: Udhrain, Ashish, et al.
Publicado: (2007)

Preoperative evaluation of the efficacy of radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case series
por: Aiba, Hisaki, et al.
Publicado: (2018)

Patched Homolog 1 (PTCH1) Mutation in a CIC-Rearranged Sarcoma: Lack of Response to the Smoothened (SMO) Vismodegib
por: Wu, David J, et al.
Publicado: (2023)

Protein kinase activity is associated with CD63 in melanoma cells
por: Iida, Joji, et al.
Publicado: (2005)

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas
por: Monga, Varun, et al.
Publicado: (2020)

Adjuvant Chemotherapy of Soft Tissue Sarcoma—Current Status
por: Judson, Ian
Publicado: (2000)

Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas
por: Loong, Herbert H., et al.
Publicado: (2018)

Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer
por: Nikas, Jason B., et al.
Publicado: (2011)

Gene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors
por: Skubitz, Keith M., et al.
Publicado: (2016)

Chemotherapy for metastatic soft tissue sarcomas--another full circle?
por: Bramwell, V. H.
Publicado: (1991)

Adjuvant chemotherapy in soft tissue sarcomas…Conflicts, consensus, and controversies
por: Bajpai, Jyoti, et al.
Publicado: (2016)

Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum
por: Boylan, Kristin LM, et al.
Publicado: (2010)

Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma
por: OUYANG, ZHENGXIAO, et al.
Publicado: (2013)

Perspectives of Cell Sensitivity/Resistance Assay in Soft Tissue Sarcomas Chemotherapy
por: Fetisov, Timur I., et al.
Publicado: (2023)

Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
por: Brodowicz, Thomas, et al.
Publicado: (2000)

Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study
por: Hall, Kirsten Sundby, et al.
Publicado: (2020)

A multiplex platform for the identification of ovarian cancer biomarkers
por: Boylan, Kristin L. M., et al.
Publicado: (2017)

Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma
por: Minchom, Anna, et al.
Publicado: (2010)

Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs
por: Zong, Xiang-Yun, et al.
Publicado: (2009)

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma
por: Yousaf, Nadia, et al.
Publicado: (2015)

Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
por: Patel, Ronak, et al.
Publicado: (2019)

Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma
por: Torrigiani, Filippo, et al.
Publicado: (2019)

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy
por: Virgili Manrique, Anna C., et al.
Publicado: (2022)

Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)

Standardization of evaluation method and prognostic significance of histological response to preoperative chemotherapy in high-grade non-round cell soft tissue sarcomas
por: Oda, Yoshinao, et al.
Publicado: (2022)

Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics
por: Boylan, Kristin L. M., et al.
Publicado: (2021)

Long-Term Neurotoxicity of Chemotherapy in Adolescents and Young Adults Treated for Bone and Soft Tissue Sarcomas
por: Earl, Helena M., et al.
Publicado: (1998)

A Retrospective Analysis of Vinorelbine Chemotherapy for Patients With Previously Treated Soft-Tissue Sarcomas
por: Anderson, Sibyl E., et al.
Publicado: (2006)

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience
por: Brunello, Antonella, et al.
Publicado: (2015)

Analysis of Dietary Intake during Consecutive-Day Chemotherapy for Bone and Soft-Tissue Sarcomas
por: Hori, Yuta, et al.
Publicado: (2018)

Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma
por: Graham, Danielle S., et al.
Publicado: (2020)

Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials.
por: Ravaud, A., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_1k1pvvt375vml6745j0c4bitg4